Mexiletine: Anti arrhythmic drug.
Mexitil cap ( Zy.Cad (G.Rem))
Mexitil inj [ Zy.Cad (G.Rem)]
Mexiletine is a prescription drug available from your pharmacy store only with the prescription of a qualified medical practitioner.
Mexiletine pronounced as: mex-IL-e-teen
Mexiletine is an anti arrhythmic drug.
Mexiletine is used for treating life threatening heart rhythm disturbances like ventricular fibrillation, ventricular tachycardia.
Do not take mexiletine if you have heart problems.
Pregnant woman: Mexiletine belongs to FDA pregnancy category C. This means that mexiletine may harm an unborn baby if used during pregnancy but potential benefit may warrant use of the drug in pregnant woman despite potential risks. Always inform your doctor if you are pregnant or are planning for conception.
Lactating women: It is not known whether mexiletine passes into breast milk or if it could harm the baby. Do not take mexiletine with out first talking to doctor if you are breast feeding a baby.
Mexiletine is available as injection and tablet. Your doctor will prescribe it depending on the severity of the condition.
Use as directed by your physician, your physician prescribes depending on the severity of disease. Use the complete course of medication as prescribed by your physician even though you feel better after one or two days of usage of medication.
If it is almost the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not take two doses at same time to cover up the missed dose.
In case of overdose contact your nearest poison control centre or emergency medical centre for immediate care by physician.
The overdose symptoms of mexiletine are
Mexiletine may cause following side effects
Consult your doctor immediately if notice following symptoms.
Store mexiletine at room temp (15 – 30 degrees C). Avoid excessive heat, moisture or direct sunlight, never store in the bathroom.Keep it out of reach of children. Make sure that any leftover portion is disposed off safely.
Written by: Healthplus24 team
Date last updated: July 16, 2011
Subscribe to our email newsletter.